Moving from 5mg to 7.5mg Mounjaro: what actually changes

You've finished your 5mg pen — here's where you actually are

Picture this: your last 5mg pen is sitting in the sharps bin, you feel like the nausea has finally quietened down, and you're wondering whether the 7.5mg pen is going to undo all of that. It's the question our prescribers hear regularly, and the honest answer is: possibly a little, briefly, and for most people not as badly as the very first dose.

The 5mg strength sits at the end of Mounjaro's two-dose starter phase. The 2.5mg pen is designed to let your digestive system adjust to tirzepatide at all; the 5mg pen consolidates that. By the time you move to 7.5mg you are crossing into what the licensed schedule considers the first genuinely therapeutic tier, the doses where the dual GIP and GLP-1 receptor activation begins to produce the appetite suppression and metabolic effects that the clinical programme was built around. You can read more about the full dose ladder on the Mounjaro treatment overview page.

A useful thing to know: SURMOUNT-1, which followed 2,539 adults across 72 weeks, reported around 20–21% average body-weight reduction at the 15mg maintenance dose, but that figure only becomes possible if patients move through the middle doses steadily and safely, and for those who need more information about the highest available strength, our tirzepatide 80 mg page explains what that option involves. The SURMOUNT-1 paper in the New England Journal of Medicine is publicly available if you want to read the underlying evidence.

What a dose increase to 7.5mg tends to feel like

The most predictable thing about stepping up to 7.5mg is that your gut will notice. Nausea, a feeling of fullness that arrives faster than you expect, and the occasional bout of loose stools are the most commonly reported effects in the early weeks at any new dose level. The NHS tirzepatide medicines page lists these clearly, and the pattern is the same: most intense in the first week or two after a dose change, then fading as your body recalibrates.

For many people the 7.5mg adjustment is actually gentler than the very first injection, simply because the GI system has had four to eight weeks to get used to the medicine. That said, it varies. A few things tend to make the transition easier: eating smaller portions, avoiding very fatty or rich meals, staying well hydrated, and not injecting on an evening when you have somewhere to be the next morning. If you inject on a Monday, you'll likely feel the peak effect around Tuesday, worth factoring in before a busy Wednesday, let alone before the school run.

Importantly, these are general patterns based on trial data and the licensed prescribing information. What matters for your situation is your own prescriber's guidance and the Patient Information Leaflet that comes with your pen. The leaflet is the authoritative source for what to do if side effects become difficult or prolonged.

The 7.5mg Mounjaro page covers what to expect at this specific strength in more detail.

What your prescriber is actually checking before approving 7.5mg

A dose increase is not automatic at four weeks. When you come back for a review, your prescriber is looking at a few things: whether you have been tolerating 5mg without persistent or severe side effects, whether your weight has been responding, and whether there are any new clinical factors to consider. At nume, every repeat order goes through the same clinical review process, a real prescriber reads your update, they do not pass it to a system to rubber-stamp.

If there are signs that 5mg is not yet sitting comfortably, staying at that dose for a further four weeks is a reasonable and common outcome. The licensed schedule allows for that. Equally, if you have been doing well, the step to 7.5mg is straightforward to approve. The key point is that the evidence and the safety infrastructure around this medicine exist precisely because dose decisions have clinical consequences, they are not a formality. Our clinical team oversees these reviews.

If you are curious about how the 5mg-to-7.5mg step fits into the broader titration picture, the earlier dose step from 2.5mg to 5mg explains the principles that carry forward at each increase.

Cost, supply, and a sensible note on the 7.5mg pen

One practical question that comes up at this stage is cost. Moving to a higher dose means a different pen, and UK pricing for Mounjaro changed significantly from September 2025 when Eli Lilly revised its UK list price, the details of that price change are worth reading if you are planning ahead. Private treatment costs vary by dose and provider, and it is reasonable to factor in what a 7.5mg monthly supply will cost versus the 5mg you have been using.

At nume, the price you see on the treatment page covers the clinical consultation, the prescription, the medicine and next-working-day DPD delivery, nothing added at checkout. If you order before midday on a working day and your prescriber approves the dose increase the same day, the pen is dispatched that afternoon. That is the full process. No subscription is created; the next order goes through the same clinical review.

One reassurance worth stating plainly: the 7.5mg pen works exactly the same way as the pens you have already used. It is the same KwikPen format, same injection technique, same rotation of sites, abdomen, thigh or upper arm. The 7.5mg pen guide covers the practical details if you want them before your pen arrives.